TY - JOUR
T1 - Identification of NR5A1 (SF-1/AD4BP) gene expression modulators by large-scale gain and loss of function studies
AU - Sakai, Noriko
AU - Terami, Hiromi
AU - Suzuki, Shinobu
AU - Haga, Megumi
AU - Nomoto, Ken
AU - Tsuchida, Nobuko
AU - Morohashi, Ken Ichirou
AU - Saito, Naoaki
AU - Asada, Maki
AU - Hashimoto, Megumi
AU - Harada, Daisuke
AU - Asahara, Hiroshi
AU - Ishikawa, Tetsuya
AU - Shimada, Fumiki
AU - Sakurada, Kazuhiro
PY - 2008/9
Y1 - 2008/9
N2 - Nuclear receptor subfamily 5, group A, member 1 (NR5A1 previously known as SF-1/AD4BP) is a transcription factor involved in the development of adrenal/gonadal tissues and steroidogenic linage cell diffierentiation in adult somatic stem cells. To understand the cellular signaling network that regulates NR5A1 gene expression, loss of function screening with an siRNA kinome library, and gain of function screening with an addressable full-length cDNA library representing one quarter of the human genome was carried out. The NR5A1 gene expression was activated in mesenchymal stem cells by siRNA directed against protein kinase C (PKC)-δ, erb-B3, RhoGAP (ARHGAP26), and hexokinase 2, none of which were previously known to be involved in the NR5A1 gene expression. Among these, we identified crosstalk between erb-B3 and PKC-δ signaling cascades. In addition, the gain of function studies indicated that sex-determining region Y (SRY)-box 15 (SOX15), TEA domain family member 4, KIAA1257 (a gene of unknown function), ADAM metallopeptidase with thrombospondin type 1 motif 6, Josephin domain containing 1, centromere protein, TATA box-binding protein-associated factor 5-like RNA polymerase, and inducible T-cell co-stimulator activate NR5A1 gene expression. These results provide new insights into the molecular mechanisms of NR5A1 gene expression.
AB - Nuclear receptor subfamily 5, group A, member 1 (NR5A1 previously known as SF-1/AD4BP) is a transcription factor involved in the development of adrenal/gonadal tissues and steroidogenic linage cell diffierentiation in adult somatic stem cells. To understand the cellular signaling network that regulates NR5A1 gene expression, loss of function screening with an siRNA kinome library, and gain of function screening with an addressable full-length cDNA library representing one quarter of the human genome was carried out. The NR5A1 gene expression was activated in mesenchymal stem cells by siRNA directed against protein kinase C (PKC)-δ, erb-B3, RhoGAP (ARHGAP26), and hexokinase 2, none of which were previously known to be involved in the NR5A1 gene expression. Among these, we identified crosstalk between erb-B3 and PKC-δ signaling cascades. In addition, the gain of function studies indicated that sex-determining region Y (SRY)-box 15 (SOX15), TEA domain family member 4, KIAA1257 (a gene of unknown function), ADAM metallopeptidase with thrombospondin type 1 motif 6, Josephin domain containing 1, centromere protein, TATA box-binding protein-associated factor 5-like RNA polymerase, and inducible T-cell co-stimulator activate NR5A1 gene expression. These results provide new insights into the molecular mechanisms of NR5A1 gene expression.
UR - http://www.scopus.com/inward/record.url?scp=53349127742&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=53349127742&partnerID=8YFLogxK
U2 - 10.1677/JOE-08-0027
DO - 10.1677/JOE-08-0027
M3 - Article
C2 - 18579725
AN - SCOPUS:53349127742
SN - 0022-0795
VL - 198
SP - 489
EP - 497
JO - Journal of Endocrinology
JF - Journal of Endocrinology
IS - 3
ER -